Business TimesBusiness
Analysts cut Wilmar target on costs, regulatory risks
Analysts have lowered their price targets for Wilmar, citing regulatory uncertainty and rising raw material costs. The company’s earnings for the nine months ended September 30 also came in below bank estimates, adding pressure to investor expectations.
This card is an AI-assisted summary of reporting published by Business Times. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.